U.S. FDA clears Pfizer’s COVID-19 booster shot for 12- to 15-year-olds -Breaking
[ad_1]
© Reuters. FILE PHOTO: Brendan Lo (13 years old) receives an injection of Pfizer BioNTech vaccine against coronavirus diseases (COVID-19), at Northwell Health’s Cohen Children’s Medical Center, New Hyde Park. This was taken on May 13, 2021. REUTERS/Shannon Stapleton(Reuters) – Monday’s approval by the U.S. Food and Drug Administration for the use of a third-dose of the medication Pfizer (NYSE:) The BioNTech COVID-19 vaccine is for children between 12-15 years old.
Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.
[ad_2]